Moreover, KRAS and TP53 gene mutations have been detected in alveolar type II pneumocytes of lung tissue from IPF patients, and their protein upregulation, which causes an imbalance in different growth factors, has also been associated with increased lung tumorigenesis [24]. This evidence concerns the gene TP53 and idiopathic interstitial pneumonia.